Robert W Van Leen

Title: The Innovations of Robert W Van Leen

Introduction

Robert W Van Leen is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of human interleukin-3 (hIL-3) and its variants. With a total of 3 patents, his work has implications for pharmaceutical compositions and therapeutic applications.

Latest Patents

One of his latest patents focuses on N- and C-terminal truncation and deletion mutants of human interleukin-3. This patent provides biologically active deletion and substitution mutants of hIL-3, with preferred mutants having deletions at the N-terminus and/or the C-terminus. Additionally, it includes specific substitution mutants that can be utilized in formulating pharmaceutical compositions. Another significant patent involves methods for the expression and purification of human interleukin-3 and its muteins. This patent outlines improved production methods for hIL-3, either in glycosylated form from mammalian and yeast cells or in unglycosylated form from prokaryotes.

Career Highlights

Robert W Van Leen has been associated with Gist-Brocades N.V., where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding and application of interleukin-3 in medical science.

Collaborations

Throughout his career, Robert has collaborated with esteemed colleagues, including Lambertus C Dorssers and Albert J Van Ooyen. These collaborations have further enriched his research and innovation efforts.

Conclusion

Robert W Van Leen's contributions to biotechnology, particularly in the realm of human interleukin-3, highlight his innovative spirit and dedication to advancing medical science. His patents and collaborative efforts continue to influence the field positively.